Senate Files

Bills

S. 3014 119th Congress

Ensuring Timely Access to Generics Act of 2025

Latest action, Oct 16, 2025: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

How the Senate voted

The Senate hasn't taken a roll call on this bill in the Congresses covered.

2 cosponsors

Sponsored by Jeanne Shaheen (Democrat). Cosponsors by party, House members included:

  • Democrats
  • Republicans
  • Independents
Cosponsors
1 D · 1 R
  • Democrat
  • Republican
  • Independent
2 senators cosponsoring

Referred to: Senate: Health, Education, Labor, and Pensions Committee

Who lobbied on it

Clients whose quarterly lobbying reports named it, each quarter.

26 clientsQ1 2026Q3 2026

The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.

BCBSM INC
3 reports
BLUE CROSS AND BLUE SHIELD ASSOCIATION
3 reports
BLUE CROSS AND BLUE SHIELD OF FLORIDA INC
3 reports
BLUE CROSS AND BLUE SHIELD OF KANSAS INC
3 reports
BLUE CROSS BLUE SHIELD OF MICHIGAN
3 reports
BLUECROSS BLUESHIELD OF TENNESSEE
3 reports
GUIDEWELL MUTUAL HOLDING CORPORATION
3 reports
THE CAMPAIGN FOR SUSTAINABLE RX PRICING
MEHLMAN CONSULTING, INC.
3 reports
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
2 reports
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2 reports
AMGEN
THE NICKLES GROUP, LLC
2 reports
AMGEN INC
2 reports
ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)
FIERCE GOVERNMENT RELATIONS
2 reports
BIOTECHNOLOGY INNOVATION ORGANIZATION
2 reports
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
2 reports
The top 25 of 27 clients, by reports
ClientLobbying firmReportsReports totalingFromToSenate
BCBSM INC3$88KQ1 2026Q3 2026yes
BLUE CROSS AND BLUE SHIELD ASSOCIATION3$3.8MQ1 2026Q3 2026yes
BLUE CROSS AND BLUE SHIELD OF FLORIDA INC3$310KQ1 2026Q3 2026yes
BLUE CROSS AND BLUE SHIELD OF KANSAS INC3$30KQ1 2026Q3 2026yes
BLUE CROSS BLUE SHIELD OF MICHIGAN3$829KQ1 2026Q3 2026yes
BLUECROSS BLUESHIELD OF TENNESSEE3$780KQ1 2026Q3 2026yes
GUIDEWELL MUTUAL HOLDING CORPORATION3$30KQ1 2026Q3 2026yes
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGMEHLMAN CONSULTING, INC.3$270KQ1 2026Q3 2026yes
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)2$6.0MQ2 2026Q3 2026yes
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS2$510KQ2 2026Q3 2026yes
AMGENTHE NICKLES GROUP, LLC2$0Q2 2026Q3 2026yes
AMGEN INC2$5.6MQ2 2026Q3 2026yes
ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)FIERCE GOVERNMENT RELATIONS2$120KQ2 2026Q3 2026yes
BIOTECHNOLOGY INNOVATION ORGANIZATION2$4.9MQ2 2026Q3 2026yes
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)2$710KQ2 2026Q3 2026yes
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)WHITMER & WORRALL, LLC2$100KQ1 2026Q2 2026yes
GSK (FKA GLAXOSMITHKLINE INC.)2$2.4MQ2 2026Q3 2026yes
KAISER FOUNDATION HEALTH PLAN INC2$1.0MQ2 2026Q3 2026yes
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2$14.4MQ2 2026Q3 2026yes
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICACROSSROADS STRATEGIES, LLC2$0Q2 2026Q3 2026yes
AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERSARENTFOX SCHIFF LLP1$50KQ2 2026Q2 2026yes
AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERSTHE INSTITUTE FOR FAMILY HEALTH1$25KQ2 2026Q2 2026yes
AMERICAN MEDICAL ASSOCIATION1$4.5MQ3 2026Q3 2026yes
FAMILIES USA FOUNDATION INC1$9,000Q2 2026Q2 2026yes
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATIONDAVE KOLBE CONSULTING1$30KQ2 2026Q2 2026yes